<DOC>
	<DOCNO>NCT01160679</DOCNO>
	<brief_summary>This prospective , multi-center , 12 week naturalistic NIS trial conduct 25 hospital naturalistic treatment set . There experimental component associate study observational activity part routine care visit : baseline ( week 0 ) , week 4 week 12 .</brief_summary>
	<brief_title>Effectiveness Atypical Antipsychotics Anhedonic Features Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Documented clinical diagnosis schizophrenia meeting Diagnostic Statistical Manual Mental Disorders , ( DSMIVTR ) criterion Patients already take one atypical inclusion start least 1 week 4 week inclusion Meeting criterion ( schizophrenia ) DSMIV Axis I Patients antipsychotic combination ( two agent ) Patients already mood stabilizer antidepressant Known lack response clozapine treatment clozapine within 4 week prior enrollment Patients treat antipsychotic depot formulation last two month Previous enrollment randomisation treatment present NIS Patients participate clinical trial within 4 week prior enrollment period Pregnant woman woman breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>anhedonic feature patient schizophrenia</keyword>
</DOC>